US Biomax, Inc.

BC111110

Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases/70 cores, replaced by OV701

Microarray Panel:Ovarial carcinoma tissue microarray, containing 59 cases of adenocarcinoma, 1 endodermal sinus carcinoma, 10 adjacent normal tissue, single core per case
Cores:70
Cases:70
Layout:10 cols × 7 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.


Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
B Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
C Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
D Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
E Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
F Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova  
G Ova Ova Ova Ova Ova Ova Ova Ova Ova Ova Marked point
Legend: Ova - Ovary

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage IIIb), - Malignant tumor (stage IIIc), - Malignant tumor (stage IIa), - Malignant tumor (stage IIb), - Malignant tumor (stage IIc), - Malignant tumor (stage IV), - Malignant tumor (stage Ia), - Malignant tumor (stage Ib), - Malignant tumor (stage Ic), - NAT

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 46 Ovary Serous papillary adenocarcinoma 1 IIb T2bN0M0 Malignant
A2 2 F 60 Ovary Serous papillary adenocarcinoma 1 IIa T2aN0M0 Malignant
A3 3 F 45 Ovary Serous papillary adenocarcinoma 1 Ia T1aN0M0 Malignant
A4 4 F 70 Ovary Serous papillary adenocarcinoma 1 Ia T1aN0M0 Malignant
A5 5 F 39 Ovary Serous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
A6 6 F 53 Ovary Serous papillary adenocarcinoma 1 Ia T1aN0M0 Malignant
A7 7 F 49 Ovary Serous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
A8 8 F 73 Ovary Serous papillary adenocarcinoma 3 Ib T1bN0M0 Malignant
A9 9 F 57 Ovary Serous papillary adenocarcinoma (fibrous tissue and blood vessel) Ic T1cN0M0 Malignant
A10 10 F 45 Ovary Serous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
B1 11 F 52 Ovary Serous papillary adenocarcinoma 2 IIIc T2N1M0 Malignant
B2 12 F 48 Ovary Serous papillary adenocarcinoma 2 IIIc T3cN0M0 Malignant
B3 13 F 48 Ovary Serous papillary adenocarcinoma 3 Ib T1bN0M0 Malignant
B4 14 F 47 Ovary Serous papillary adenocarcinoma 3 I T1N0M0 Malignant
B5 15 F 51 Ovary Serous papillary adenocarcinoma 3 IIa T2aN0M0 Malignant
B6 16 F 64 Ovary Serous papillary adenocarcinoma 3 Ia T1aN0M0 Malignant
B7 17 F 49 Ovary Serous papillary adenocarcinoma 2 IIIc T3cN0M0 Malignant
B8 18 F 51 Ovary Serous papillary adenocarcinoma 2 IIIc T3N1M0 Malignant
B9 19 F 51 Ovary Serous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
B10 20 F 65 Ovary Serous papillary adenocarcinoma 2 IV T2aN0M1 Malignant
C1 21 F 73 Ovary Serous papillary adenocarcinoma 3 IIa T2aN0M0 Malignant
C2 22 F 54 Ovary Serous adenocarcinoma (sparse) 2 IIIb T3bN0M0 Malignant
C3 23 F 52 Ovary Serous papillary adenocarcinoma 3 IIa T2aN0M0 Malignant
C4 24 F 51 Ovary Serous papillary adenocarcinoma 3 Ia T1aN0M0 Malignant
C5 25 F 52 Ovary Serous papillary adenocarcinoma 3 Ia T1aN0M0 Malignant
C6 26 F 52 Ovary Serous papillary adenocarcinoma 3 IIIc T3cN1M0 Malignant
C7 27 F 62 Ovary Serous papillary adenocarcinoma 3 Ia T1aN0M0 Malignant
C8 28 F 48 Ovary Serous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
C9 29 F 39 Ovary Serous papillary adenocarcinoma with necrosis 3 II T2N0M0 Malignant
C10 30 F 49 Ovary Serous papillary adenocarcinoma 3 Ia T1aN0M0 Malignant
D1 31 F 55 Ovary Serous papillary adenocarcinoma 2 IV T3cN1M1 Malignant
D2 32 F 48 Ovary Serous papillary adenocarcinoma 3 Ib T1bN0M0 Malignant
D3 33 F 51 Ovary Serous papillary adenocarcinoma 3 Ib T1bN0M0 Malignant
D4 34 F 56 Ovary Serous papillary adenocarcinoma 2 IIIc T3N1M0 Malignant
D5 35 F 60 Ovary Serous papillary adenocarcinoma 3 Ib T1bN0M0 Malignant
D6 36 F 41 Ovary Serous papillary adenocarcinoma 3 IIa T2aN0M0 Malignant
D7 37 F 39 Ovary Serous papillary adenocarcinoma 3 Ib T1bN0M0 Malignant
D8 38 F 32 Ovary Serous papillary adenocarcinoma 3 IIIc T3cN0M0 Malignant
D9 39 F 54 Ovary Serous papillary adenocarcinoma 3 Ia T1aN0M0 Malignant
D10 40 F 59 Ovary Serous papillary adenocarcinoma 3 II T2N0M0 Malignant
E1 41 F 50 Ovary Serous papillary adenocarcinoma 3 Ib T1bN0M0 Malignant
E2 42 F 46 Ovary Mucinous papillary adenocarcinoma 1 Ia T1aN0M0 Malignant
E3 43 F 48 Ovary Mucinous papillary adenocarcinoma 1 Ib T1bN0M0 Malignant
E4 44 F 39 Ovary Mucinous papillary adenocarcinoma 1 Ia T1aN0M0 Malignant
E5 45 F 55 Ovary Mucinous adenocarcinoma 1 Ib T1bN0M0 Malignant
E6 46 F 23 Ovary Mucinous adenocarcinoma 1 Ic T1cN0M0 Malignant
E7 47 F 58 Ovary Mucinous papillary adenocarcinoma 1 Ia T1aN0M0 Malignant
E8 48 F 55 Ovary Mucinous papillary adenocarcinoma 1 Ib T1bN0M0 Malignant
E9 49 F 60 Ovary Mucinous papillary adenocarcinoma 1 Ia T1aN0M0 Malignant
E10 50 F 19 Ovary Mucinous papillary adenocarcinoma 1 IIa T2aN0M0 Malignant
F1 51 F 29 Ovary Mucinous papillary adenocarcinoma 2 IIa T2aN0M0 Malignant
F2 52 F 46 Ovary Mucinous papillary adenocarcinoma 2 IIa T2aN0M0 Malignant
F3 53 F 37 Ovary Mucinous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
F4 54 F 39 Ovary Mucinous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
F5 55 F 37 Ovary Mucinous adenocarcinoma 3 Ia T1aN0M0 Malignant
F6 56 F 50 Ovary Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
F7 57 F 50 Ovary Endometrioid adenocarcinoma 1 IIa T2aN0M0 Malignant
F8 58 F 68 Ovary Endometrioid adenocarcinoma 2 IIc T2cN0M0 Malignant
F9 59 F 39 Ovary Endometrioid adenocarcinoma 3 IIa T2aN0M0 Malignant
F10 60 F 15 Ovary Endodermal sinus carcinoma Ib T1bN0M0 Malignant
G1 61 F 33 Ovary Cancer adjacent normal ovary tissue NAT
G2 62 F 59 Ovary Cancer adjacent normal ovary tissue NAT
G3 63 F 57 Ovary Cancer adjacent normal ovary tissue NAT
G4 64 F 41 Ovary Cancer adjacent normal ovary tissue NAT
G5 65 F 69 Ovary Cancer adjacent normal ovary tissue NAT
G6 66 F 49 Ovary Cancer adjacent normal ovary tissue NAT
G7 67 F 49 Ovary Cancer adjacent normal ovary tissue NAT
G8 68 F 50 Ovary Cancer adjacent normal ovary tissue NAT
G9 69 F 48 Ovary Cancer adjacent normal ovary tissue NAT
G10 70 F 42 Ovary Cancer adjacent normal ovary tissue NAT
M 58 Skin Malignant melanoma (tissue marker) Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array: